Biogen Inc (NASDAQ:BIIB)

324.05
Delayed Data
As of Nov 16
 +2.33 / +0.72%
Today’s Change
249.17
Today|||52-Week Range
388.67
+1.72%
Year-to-Date

Today’s Trading

Previous close321.72
Today’s open321.82
Day’s range320.62 - 326.19
Volume1,542,063
Average volume (3 months)1,394,982
Market cap$64.8B
Data as of 4:00pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)-29.57%
Earnings growth (this year)+18.41%
Earnings growth (next 5 years)+6.46%
Revenue growth (last year)+7.81%
P/E ratio21.0
Price/Sales6.17
Price/Book5.39

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+0.42+0.13%
GILDGilead Sciences-0.58-0.83%
TLRYTilray Inc+3.21+2.99%
NBIXNeurocrine Bioscienc...-1.73-1.89%
Data as of 4:00pm ET, 11/16/2018

Financials

Next reporting dateJanuary 30, 2019
EPS forecast (this quarter)$6.73
Annual revenue (last year)$11.0B
Annual profit (last year)$2.5B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts